Feenstra TL - Search Results

1

The design of a Social Cost-Benefit Analysis of preventive interventions for toxoplasmosis: An example of the One Health approach.

Suijkerbuijk AWM, van Gils PF, Bonačić Marinović AA, Feenstra TL, Kortbeek LM, Mangen MJ, Opsteegh M, de Wit GA, van der Giessen JWB. Suijkerbuijk AWM, et al. Among authors: feenstra tl. Zoonoses Public Health. 2018 Feb;65(1):185-194. doi: 10.1111/zph.12417. Epub 2017 Nov 12. Zoonoses Public Health. 2018. PMID: 29131528

2

Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review.

Vijgen SM, Hoogendoorn M, Baan CA, de Wit GA, Limburg W, Feenstra TL. Vijgen SM, et al. Among authors: feenstra tl. Pharmacoeconomics. 2006;24(5):425-41. doi: 10.2165/00019053-200624050-00002. Pharmacoeconomics. 2006. PMID: 16706569 Review.

3

van Baal PH, Feenstra TL, Hoogenveen RT, de Wit GA, Brouwer WB. van Baal PH, et al. Among authors: feenstra tl. Health Econ. 2007 Apr;16(4):421-33. doi: 10.1002/hec.1181. Health Econ. 2007. PMID: 17039573

4

Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.

Vijgen SM, van Baal PH, Hoogenveen RT, de Wit GA, Feenstra TL. Vijgen SM, et al. Among authors: feenstra tl. Health Educ Res. 2008 Apr;23(2):310-8. doi: 10.1093/her/cym024. Epub 2007 Aug 4. Health Educ Res. 2008. PMID: 17675649

5

Lifetime medical costs of obesity: prevention no cure for increasing health expenditure.

van Baal PH, Polder JJ, de Wit GA, Hoogenveen RT, Feenstra TL, Boshuizen HC, Engelfriet PM, Brouwer WB. van Baal PH, et al. Among authors: feenstra tl. PLoS Med. 2008 Feb;5(2):e29. doi: 10.1371/journal.pmed.0050029. PLoS Med. 2008. PMID: 18254654 Free PMC article.

6

Communicating uncertainty in economic evaluations: verifying optimal strategies.

Koffijberg H, de Wit GA, Feenstra TL. Koffijberg H, et al. Among authors: feenstra tl. Med Decis Making. 2012 May-Jun;32(3):477-87. doi: 10.1177/0272989X12436725. Epub 2012 Feb 28. Med Decis Making. 2012. PMID: 22374111

7

[Societal costs of asthma, COPD and respiratory allergy].

Suijkerbuijk AW, de Wit GA, Wijga AH, Heijmans M, Hoogendoorn M, Rutten-van Mölken M, Maurits EE, Hoogenveen RT, Feenstra TL. Suijkerbuijk AW, et al. Among authors: feenstra tl. Ned Tijdschr Geneeskd. 2013;157(46):A6562. Ned Tijdschr Geneeskd. 2013. PMID: 24220178 Dutch.

8

[Costs and benefits of smoking].

Polder JJ, van Gils PF, Kok L, Talhout R, Feenstra TL. Polder JJ, et al. Among authors: feenstra tl. Ned Tijdschr Geneeskd. 2017;160:D833. Ned Tijdschr Geneeskd. 2017. PMID: 28181894 Dutch.

9

A social cost-benefit analysis of two One Health interventions to prevent toxoplasmosis.

Suijkerbuijk AWM, Over EAB, Opsteegh M, Deng H, Gils PFV, Bonačić Marinović AA, Lambooij M, Polder JJ, Feenstra TL, Giessen JWBV, Wit GA, Mangen MJ. Suijkerbuijk AWM, et al. Among authors: feenstra tl. PLoS One. 2019 May 10;14(5):e0216615. doi: 10.1371/journal.pone.0216615. eCollection 2019. PLoS One. 2019. PMID: 31075130 Free PMC article.

10

Mapping chronic disease prevalence based on medication use and socio-demographic variables: an application of LASSO on administrative data sources in healthcare in the Netherlands.

Füssenich K, Boshuizen HC, Nielen MMJ, Buskens E, Feenstra TL. Füssenich K, et al. Among authors: feenstra tl. BMC Public Health. 2021 Jun 2;21(1):1039. doi: 10.1186/s12889-021-10754-4. BMC Public Health. 2021. PMID: 34078308 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page